Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hepatobiliary therapeutic procedures

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44412   clinical trials with a EudraCT protocol, of which   7421   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5 result(s) found for: Hepatobiliary therapeutic procedures. Displaying page 1 of 1.
    EudraCT Number: 2014-004224-22 Sponsor Protocol Number: TEMOPEDI Start Date*: 2015-12-08
    Sponsor Name:Université catholique de Louvain
    Full Title: Temocillin pharmacokinetics in paediatrics
    Medical condition: Male or female patient requiring temocillin a. for the treatment of urinary tract infections, or b. for the treatment of suspicion of cholangitis associated with cirrhosis, or c. as antibiotic pro...
    Disease: Version SOC Term Classification Code Term Level
    18.1 10042613 - Surgical and medical procedures 10024714 Liver transplant PT
    18.1 10019805 - Hepatobiliary disorders 10004607 Bile duct infections and inflammations HLT
    18.1 10042613 - Surgical and medical procedures 10042613 Surgical and medical procedures SOC
    18.1 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    18.1 10021881 - Infections and infestations 10021879 Infections - pathogen unspecified HLGT
    18.1 10021881 - Infections and infestations 10021881 Infections and infestations SOC
    18.1 10042613 - Surgical and medical procedures 10019704 Hepatic therapeutic procedures HLT
    18.1 10019805 - Hepatobiliary disorders 10008605 Cholangitis acute PT
    18.1 10019805 - Hepatobiliary disorders 10019805 Hepatobiliary disorders SOC
    18.1 10042613 - Surgical and medical procedures 10019818 Hepatobiliary therapeutic procedures HLGT
    18.1 10019805 - Hepatobiliary disorders 10004606 Bile duct disorders HLGT
    18.1 10042613 - Surgical and medical procedures 10024716 Liver transplantation LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000952-32 Sponsor Protocol Number: BAY86-4873/16078 Start Date*: 2015-09-24
    Sponsor Name:Bayer HealthCare AG
    Full Title: Open-label, multi-center study to evaluate the safety, efficacy, and plasma gadolinium concentrations after an intravenous injection of 0.1 mL/kg body weight Eovist/Primovist for enhanced magnetic ...
    Medical condition: Magnetic Resonance Imaging
    Disease: Version SOC Term Classification Code Term Level
    18.0 10022891 - Investigations 10072304 Nuclear magnetic resonance imaging liver PT
    Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2021-001445-12 Sponsor Protocol Number: GS-US-454-6075 Start Date*: 2022-02-25
    Sponsor Name:Gilead Sciences, Inc.
    Full Title: A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and...
    Medical condition: Nonalcoholic Steatohepatitis (NASH)
    Disease: Version SOC Term Classification Code Term Level
    24.1 10019805 - Hepatobiliary disorders 10053219 Non-alcoholic steatohepatitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-004692-53 Sponsor Protocol Number: SJ-434 Start Date*: 2017-03-01
    Sponsor Name:Zealand University Hospital Køge
    Full Title: Changes in bile acid homeostasis and stool habits after cholecystectomy
    Medical condition: Post cholecystectomy bile acid diarrhoea/malabsorption
    Disease: Version SOC Term Classification Code Term Level
    19.1 10017947 - Gastrointestinal disorders 10069703 Bile acid malabsorption PT
    19.1 10042613 - Surgical and medical procedures 10008611 Cholecystectomy PT
    19.1 10017947 - Gastrointestinal disorders 10066557 Chronic diarrhoea LLT
    19.1 10019805 - Hepatobiliary disorders 10057229 Post cholecystectomy syndrome PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-000707-20 Sponsor Protocol Number: AFM24-102 Start Date*: 2021-09-07
    Sponsor Name:Affimed GmbH
    Full Title: A Phase 1/2a Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of AFM24 in Combination with Atezolizumab in Patients with Selected Advanced/Metastatic...
    Medical condition: Advanced/Metastatic EGFR-expressing Cancers
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004864 10048683 Advanced cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) PL (Trial now transitioned)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Oct 16 08:36:07 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA